Genetic study identifies 18 possible MS drug targets
Key Takeaway
A study of genetic and protein data identified 18 possible targets for future MS drugs.
What They Found
Researchers compared genetic data from people with and without MS. They also studied protein data from blood and brain samples. Their analyses identified 18 proteins that may play a role in MS risk. Existing drugs for other conditions target six of these proteins, but this study did not test those drugs. A separate set of protein data supported findings for 10 of the possible targets.
Who Should Care and Why
The genetic comparison included people with MS and people without MS. The study looked for possible starting points for MS drug research. Some of the proteins were found in blood, while others were found in brain data. Researchers also found that some existing drugs target these proteins. The findings do not show whether those drugs help people with MS.
Important Considerations
You should know this was an analysis of genetic and protein data, not a drug trial. The genetic comparison included 14,802 people with MS and 26,703 people without MS. The study cannot show whether targeting these proteins would treat MS.
AI-generated summary — for informational purposes only, not medical advice
Categories:
Article Topics:
You May Also Like
11/1/2026
Researchers compared blood from people with childhood-onset MS and healthy volunteers. They found DN
Read More
11/1/2026
In 24 people with severe MS, stem cell treatment lowered signs of inflammation and nerve damage for
Read More
11/1/2026
A review of 49 studies finds special brain scans can detect MS-related inflammation, but scan method
Read More
11/1/2026
In a study of 294 pregnancies, MS flare-ups were uncommon after pausing two treatments. Learn what t
Read More
10/9/2026
A mouse study suggests prepared red blood cells may calm MS-like immune attacks. Learn why liver cel
Read More
10/9/2026
See how lab-grown nerve cells move a key protein, why this may matter for nerve health, and why the
Read MoreUnderstanding MS Research
Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Proceedings of the National Academy of Sciences of the United States of America often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.